These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 13846147)

  • 21. [Effects of 17-alpha-hydroxyprogesterone caproate in 100 cases of threatened abortion].
    CASTELAZO AYALA L; ESPINOSA DE LOS REYES V; GONZALEZ RAMOS M; REYES CEJA L
    Ginecol Obstet Mex; 1959; 14():249-61. PubMed ID: 13808265
    [No Abstract]   [Full Text] [Related]  

  • 22. Metabolism of 17 alpha-hydroxyprogesterone-4-C14-17 alpha-caproate by homogenates of rat liver and human placenta.
    WIENER M; LUPU CI; PLOTZ EJ
    Acta Endocrinol (Copenh); 1961 Apr; 36():511-9. PubMed ID: 13785108
    [No Abstract]   [Full Text] [Related]  

  • 23. Quantitation of hydroxyprogesterone caproate, medroxyprogesterone acetate, and progesterone by reversed-phase high-pressure liquid chromatography.
    Das Gupta V
    J Pharm Sci; 1982 Mar; 71(3):294-7. PubMed ID: 6461754
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [ACTION OF 3 DERIVATIVES OF 17-ALPHA-ACETOXYPROGESTERONE ON THE ESTABLISHMENT OF PREGNANCY IN THE CASTRATED RABBIT].
    CHAMBON Y
    C R Hebd Seances Acad Sci; 1965 Jan; 260():690-3. PubMed ID: 14282907
    [No Abstract]   [Full Text] [Related]  

  • 25. Failure of hydroxyprogesterone caproate to maintain pregnancy in ovariectomised mares.
    McKinnon AO; Tarrida del Marmol Figueroa S; Nobelius AM; Hyland JH; Vasey JR
    Equine Vet J; 1993 Mar; 25(2):158-60. PubMed ID: 8467776
    [No Abstract]   [Full Text] [Related]  

  • 26. [Research on the maintenance of pregnancy by 17 alpha-hydroxyprogesterone caproate in the castrated pregnant rabbit].
    SUCHOWSKY G; JUNKMANN K
    Acta Endocrinol (Copenh); 1958 Jun; 28(2):129-31. PubMed ID: 13532385
    [No Abstract]   [Full Text] [Related]  

  • 27. [Preparation of 17 alpha-hydroxy-progesterone caproate-(4-C14)].
    SCHULZE PE
    Z Naturforsch B; 1958 Jun; 13B(6):409-10. PubMed ID: 13581937
    [No Abstract]   [Full Text] [Related]  

  • 28. Predictors of response to 17-alpha hydroxyprogesterone caproate for prevention of recurrent spontaneous preterm birth.
    Manuck TA; Esplin MS; Biggio J; Bukowski R; Parry S; Zhang H; Huang H; Varner MW; Andrews W; Saade G; Sadovsky Y; Reddy UM; Ilekis J;
    Am J Obstet Gynecol; 2016 Mar; 214(3):376.e1-8. PubMed ID: 26692181
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 17-alpha hydroxyprogesterone caproate for preterm birth prevention: Where have we been, how did we get here, and where are we going?
    Manuck TA
    Semin Perinatol; 2017 Dec; 41(8):461-467. PubMed ID: 28947068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 17-Alpha-hydroxyprogesterone-caproate: a new substance with prolonged progestational activity; a comparison with chemically pure progesterone.
    DAVIS ME; WIED GL
    J Clin Endocrinol Metab; 1955 Aug; 15(8):923-30. PubMed ID: 13242645
    [No Abstract]   [Full Text] [Related]  

  • 31. [Long-acting progestin: 17-alpha-hydroxyprogesterone-N-caproate].
    ANSELMI F; DELLA BELLA D
    Boll Soc Ital Biol Sper; 1955; 31(11-12):1639-43. PubMed ID: 13329249
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical and histopathologic evaluation of the effect of 17-alpha-hydroxyprogesterone-17-n-caproate on endometral carcinoma.
    VARGA A; HENRIKSEN E
    Obstet Gynecol; 1961 Dec; 18():658-72. PubMed ID: 13924838
    [No Abstract]   [Full Text] [Related]  

  • 33. Double-blind study of effect of 17-hydroxyprogesterone caproate on abortion rate.
    SHEARMAN RP; GARRETT WJ
    Br Med J; 1963 Feb; 1(5326):292-5. PubMed ID: 13977012
    [No Abstract]   [Full Text] [Related]  

  • 34. Prevention of preterm birth with vaginal progesterone or 17-alpha-hydroxyprogesterone caproate: a critical examination of efficacy and safety.
    O'Brien JM; Lewis DF
    Am J Obstet Gynecol; 2016 Jan; 214(1):45-56. PubMed ID: 26558340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Response to 17-alpha hydroxyprogesterone caproate.
    Frappaolo A; Vadnais M
    Am J Obstet Gynecol; 2018 Aug; 219(2):217. PubMed ID: 29698618
    [No Abstract]   [Full Text] [Related]  

  • 36. Observations on the use of 17-alpha-hydroxy-progesterone caproate on primary metastatic endometrial carcinoma.
    KISTNER RW; BAGINSKY S
    Surg Forum; 1961; 12():424-6. PubMed ID: 14456488
    [No Abstract]   [Full Text] [Related]  

  • 37. HYDROXYPROGESTERONE caproate.
    J Am Med Assoc; 1957 Feb; 163(5):356-7. PubMed ID: 13385161
    [No Abstract]   [Full Text] [Related]  

  • 38. In an in-vitro model using human fetal membranes, 17-α hydroxyprogesterone caproate is not an optimal progestogen for inhibition of fetal membrane weakening.
    Kumar D; Moore RM; Mercer BM; Mansour JM; Mesiano S; Schatz F; Lockwood CJ; Moore JJ
    Am J Obstet Gynecol; 2017 Dec; 217(6):695.e1-695.e14. PubMed ID: 29031893
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Maintenance of pregnancy in ovariectomized rats with some newer progestins.
    STUCKI JC
    Proc Soc Exp Biol Med; 1958 Nov; 99(2):500-4. PubMed ID: 13601917
    [No Abstract]   [Full Text] [Related]  

  • 40. Different effects of estrogen and progesterone on experimental atherosclerosis in female versus male rabbits. Quantification of cellular proliferation by bromodeoxyuridine.
    Hanke H; Hanke S; Finking G; Muhic-Lohrer A; Mück AO; Schmahl FW; Haasis R; Hombach V
    Circulation; 1996 Jul; 94(2):175-81. PubMed ID: 8674176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.